Cardiac Assist Devices – Market Insights – Europe

The European cardiac assist device market, although encumbered by recurring device recalls, will continue to grow rapidly due to new product development, expanded use across a broader patient population, and favorable reimbursement conditions. Growth will primarily be driven by temporary VADs and the expanding use of cardiac assist devices into historically undertreated patient segments.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for cardiac assist devices in Europe from 2019 through 2035.

Innovative novel devices will play a major role in changing the landscape of the cardiac assist device market.

Which device segments are expected to see product innovations?

Which key design features are competitors emphasizing?

How will procedure volumes be affected by emerging products?

Clinical trials have a strong impact on the cardiac assist device market.

Which competitors have early feasibility studies underway?

Which additional indications are expected to receive approval based on positive trial results?

Which competitors are benefiting the most from accumulating clinical evidence?

The cardiac assist device market will be primarily driven by VAD devices.

What factors influence the growth of VAD market?

How does the market growth differ for durable and temporary VADs?

Why are physicians concerned about the recent recalls and lack of competition in the durable VAD market?

What future advancements are anticipated in the durable and temporary VAD markets?

The TAH market will grow through 2035.

How does the usage of TAH vary across countries?

Who are the emerging players tapping this niche segment?

The remote hemodynamic monitoring system continues to expand.

What factors determine remote hemodynamic monitoring system usage patterns?

What are the major barriers to remote hemodynamic monitoring system adoption, and how will this change going forward?